State-of-the-art lecture on novel targets and treatments for heart diseases and diabetes

28 August 2023 (08:30 - 08:48)

Organised by:

Slides

Sign in for access options

About the speaker

Professor John Pernow

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail

Biochemical profiles and risk of cardiovascular events in patients withType 2 Diabetes: implications for choice of novel antihyperglycemic therapy

Doctor M. Elmegaard (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Effect of finerenone in patients with chronic kidney disease and type 2 diabetes by baseline anaemia status: a FIDELITY analysis

Abstract Slides Video

Presentation thumbnail

GLP1 receptor agonists exhibit antioxidant and anti-inflammatory properties in human heart tissue via the canonical GLP1 receptor expression through a AMPK-mediated pathway

Doctor E. Cordeanu (Strasbourg, FR)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

Doctor R. Mentz (Durham, US)

Abstract Slides Video

Access the full session

Session thumbnail

Novel targets and treatments for heart diseases and diabetes

The Event

Event poster

ESC Congress 2023

28 August 2023 08:30 CET

You may be interested in

Congress Session

Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Congress Presentation

Antithrombotic therapy in diabetes

Congress Session

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources